Abstract

BackgroundSouth Africa has the world’s largest HIV epidemic, but South African adolescent girls and young women (AGYW) acquire HIV at twice the rate of and seroconvert on average 5–7 years earlier than their male peers. Female caregivers (FC) are an untapped resource for HIV/STI prevention in South Africa and offer a novel opportunity to strengthen AGYW prevention efforts. This study will evaluate the effectiveness and cost-effectiveness of an evidence-based mother-daughter HIV/STI prevention program tested in the United States and adapted for South Africa, Informed Motivated Aware and Responsible Adolescents and Adults (IMARA), to decrease STI incident infections and increase HIV testing and counseling (HTC) and PrEP uptake in AGYW.MethodsThis is a 2-arm individually randomized controlled trial comparing IMARA to a family-based control program matched in time and intensity with 525 15–19-year-old Black South African AGYW and their FC-dyads in Cape Town’s informal communities. AGYW will complete baseline, 6-, and 12-month assessments. Following randomization, AGYW-FC dyads will participate in a 2-day group workshop (total 10 h) that includes joint and separate mother and daughter activities. Primary outcomes are AGYW STI incidence, HTC uptake, and PrEP uptake at 6 months. Secondary outcomes are AGYW STI incidence, HTC uptake, and PrEP uptake at 12 months, sexual behavior (e.g., condom use, number of partners), HIV incidence, and ART/PrEP adherence and intervention cost-effectiveness. AGYW who test positive for a STI will receive free treatment at the study site. HIV positive participants will be referred to ART clinics.DiscussionPrimary prevention remains the most viable strategy to stem new STI and HIV transmissions. HIV and STI disparities go beyond individual level factors, and prevention packages that include supportive relationships (e.g., FC) may produce greater reductions in HIV-risk, improve HTC and PrEP uptake, and increase linkage, retention, and adherence to care. Reducing new HIV and STI infections among South African AGYW is global public health priority.Trial registrationClinicalTrials.gov Number NCT04758390, accepted 02/16/2021.

Highlights

  • South Africa has the world’s largest Human Immunodeficiency Virus (HIV) epidemic, but South African adolescent girls and young women (AGYW) acquire HIV at twice the rate of and seroconvert on average 5–7 years earlier than their male peers

  • HIV and sexually-transmitted infection (STI) disparities go beyond individual level factors, and prevention packages that include supportive relationships (e.g., Female caregivers (FC)) may produce greater reductions in HIV-risk, improve HIV testing and counseling (HTC) and Pre-Exposure Prophylaxis (PrEP) uptake, and increase linkage, retention, and adherence to care

  • While changing behavior can reduce HIV and STI acquisition, [11] research on evidence-based interventions with strong evaluation designs is lacking for Adolescent Girls and Young Women (AGYW), especially those capitalizing on the strengths and assets of families

Read more

Summary

Introduction

South Africa has the world’s largest HIV epidemic, but South African adolescent girls and young women (AGYW) acquire HIV at twice the rate of and seroconvert on average 5–7 years earlier than their male peers. This study will evaluate the effectiveness and cost-effectiveness of an evidence-based mother-daughter HIV/STI prevention program tested in the United States and adapted for South Africa, Informed Motivated Aware and Responsible Adolescents and Adults (IMARA), to decrease STI incident infections and increase HIV testing and counseling (HTC) and PrEP uptake in AGYW. Mothers and other important female caregivers (FC) (e.g., aunts, cousins) play a central role in AGYW’s sexual behavior and development, and can be effective partners in reducing sexual risk while promoting new biomedical technologies like PrEP and HIV testing and counseling (HTC) [22, 23]. Mother-daughter communication that is open, receptive, and comfortable is associated with less risky sexual behavior in the US [26, 30,31,32,33,34,35,36,37] and in Africa [38,39,40,41,42,43]

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call